Botulinum toxin type A vs anticholinergics
Withdrawals due to adverse events · cervical dystonia
It is very uncertain whether botulinum toxin type A changes tolerability assessed by dropouts due to adverse events compared with anticholinergics (very low certainty).
1 finding from 1 review
- Botulinum toxin type A versus anticholinergics for cervical dystonia 2021 · Cochrane Headline outcomes onlyRR 0.33 [0.04, 3.04]Studies not reportedVery low